Literature DB >> 7963468

Computer registration of infections used to measure the effect of prophylactic antibiotics on postoperative infections following osteosynthesis in hip fractures.

H Aagaard1, H H Noer, M Scavenius, P S Jørgensen, C Tørholm.   

Abstract

Continuous registration of operations and wound infections was used to demonstrate the effect of prophylactic antibiotics in hip fracture osteosynthesis. In order to monitor wound infections and other postoperative complications in an orthopaedic department, 2 years' data on 688 patients with hip fractures, were entered into a personal computer program. During 1990, there was no formal policy for antibiotic prophylaxis; during 1991 prophylactic cefuroxime was recommended for osteosynthesis of hip fractures. In 1990 56% of patients were given prophylaxis and in 1991 this rose to 79%. Overall, 68% of patients had prophylaxis. The overall rate of deep wound infections (DWI) was significantly lower in patients treated with prophylactic antibiotics (0.6%), compared with those without prophylaxis (4.6%). Patients with DWI were admitted to the hospital for an average of 43.7 days, compared with 14.6 days for patients without complications. We recommend the use of prophylactic cefuroxime in hip fracture osteosynthesis. Computer registration of complications is a useful method for clinical quality control in an orthopaedic department.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7963468     DOI: 10.1016/0195-6701(94)90113-9

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  2 in total

1.  [Results before and after introduction of perioperative antibiotic prophylaxis in hip joint prostheses treatment of geriatric patients].

Authors:  W Kaiser; V Gulielmos; H Hausmann; S Ghalehasadi
Journal:  Unfallchirurgie       Date:  1996-08

2.  Effect of inpatient quality of care on functional outcomes in patients with hip fracture.

Authors:  Albert L Siu; Kenneth S Boockvar; Joan D Penrod; R Sean Morrison; Ethan A Halm; Ann Litke; Stacey B Silberzweig; Jeanne Teresi; Katja Ocepek-Welikson; Jay Magaziner
Journal:  Med Care       Date:  2006-09       Impact factor: 2.983

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.